With a robust background in technology and healthcare investments, the fund manager has successfully closed over 30 deals across North America and Europe. Emphasizing a data-driven approach, they have cultivated a diverse portfolio that includes several notable exits in the biotech sector. Their strategic style is characterized by a thematic focus on innovation and disruptive technologies, allowing them to identify high-potential opportunities at the growth stage. The manager's extensive experience in both operational and investment roles enhances their ability to drive value creation within their portfolio companies.